If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of HER2-positive advanced gastric or GEJ cancer in tumors expressing PD-L1 (CPS ?1) in the EU
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Augnito’s AI comprehends all English accents with 99% accuracy
Effective disaster response and management is a collaborative work
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Urges Innovators to produce quality products that can be deployed at scale
The collaboration focuses on the development and sharing of Standard Quality and Regulatory Documentation (StaQRD), a standard guide for the electronic transfer of information
Subscribe To Our Newsletter & Stay Updated
